About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage

NCT05925478·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Texas Southwestern Medical Center

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Aneurysmal subarachnoid hemorrhage with secured aneurysm
Age greater than or equal to 18 years
Able to communicate pain level

You may not be if

Documented allergy to local anesthetics (e.g. bupivicaine)
Patients with unsecured aneurysms
Patients who are unable to communicate pain level (e.g. sedation/mechanical ventilation/delirium, etc)
Medical treatment for vasospasm including blood pressure/inotropic augmentation
Angiographic treatment for vasospasm within 48 hours

The record

StatusCompleted

PhaseEarly phase 1

Taking part2

StartedNov 2023

UpdatedAug 22, 2024

Conditions

Subarachnoid Hemorrhage, Aneurysmal

Where1

UT Southwestern
Dallas, Texas, United States

Clareo Health | Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage